Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 19401-19450 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT02481427
Finnish Unicompartmental and Total Knee Arthroplasty Investigation
NAActive, not recruiting
140 participants
Started: Sep 30, 2015 · Completed: Aug 31, 2027
1 condition1 sponsor3 locations
NCT02380092
Post Market Clinical Follow Up of LEGION™ Primary TKS With VERILAST™
N/AActive, not recruiting
163 participants
Started: Sep 30, 2015 · Completed: May 31, 2029
1 condition1 sponsor7 locations
NCT02500862
Characterization of Potential Biomarkers of Eye Disease and Vision
N/AActive, not recruiting
100 participants
Started: Sep 30, 2015 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT02546973
Quality of Life in Patients With Anal Cancer
N/AActive, not recruiting
300 participants
Started: Sep 30, 2015 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT02438839
Curative Chemoradiation of Low Rectal Cancer
N/AActive, not recruiting
105 participants
Started: Sep 30, 2015 · Completed: Dec 31, 2026
1 condition1 sponsor5 locations
NCT02379520
HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
PHASE1Active, not recruiting
32 participants
Started: Sep 30, 2015 · Completed: Oct 31, 2033
6 conditions3 sponsors1 location
NCT05436730
"Escape Phenomenon of the Antihypertensive Therapy Efficacy"
N/AActive, not recruiting
165 participants
Started: Sep 29, 2015 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT04957251
Anterior vs Posterior Approach for Hip Hemiarthroplasty
NAActive, not recruiting
10 participants
Started: Sep 28, 2015 · Completed: Oct 1, 2025
1 condition1 sponsor0 locations
NCT02623933
MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer Patients
NAActive, not recruiting
60 participants
Started: Sep 24, 2015 · Completed: May 13, 2027
1 condition1 sponsor1 location
NCT04993261
An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors
EARLY_PHASE1Active, not recruiting
71 participants
Started: Sep 23, 2015 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT02397083
Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer
PHASE2Active, not recruiting
102 participants
Started: Sep 23, 2015 · Completed: Sep 30, 2026
3 conditions2 sponsors18 locations
NCT03070366
Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC
PHASE2Active, not recruiting
78 participants
Started: Sep 21, 2015 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT02444741
Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
PHASE1/PHASE2Active, not recruiting
126 participants
Started: Sep 17, 2015 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT05096299
OCS Heart EXPAND + CAP Continued Follow-Up
N/AActive, not recruiting
150 participants
Started: Sep 16, 2015 · Completed: Aug 31, 2026
1 condition1 sponsor0 locations
NCT02184013
Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study
NAActive, not recruiting
52 participants
Started: Sep 14, 2015 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT02224781
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
PHASE3Active, not recruiting
267 participants
Started: Sep 8, 2015 · Completed: Sep 11, 2026
5 conditions1 sponsor843 locations
NCT02664883
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
N/AActive, not recruiting
37 participants
Started: Sep 8, 2015 · Completed: Oct 29, 2025
6 conditions2 sponsors1 location
NCT02530463
Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome
PHASE2Active, not recruiting
99 participants
Started: Sep 8, 2015 · Completed: Sep 30, 2027
3 conditions2 sponsors1 location
NCT02314702
Post Market Clinical Follow-Up Study Protocol for PROFEMUR® L Revision Femoral Stems
N/AActive, not recruiting
26 participants
Started: Sep 4, 2015 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT03119584
Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation
PHASE4Active, not recruiting
23 participants
Started: Sep 1, 2015 · Completed: Jan 30, 2025
2 conditions1 sponsor1 location
NCT02600156
Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors
NAActive, not recruiting
7 participants
Started: Sep 1, 2015 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT02441933
Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)
PHASE3Active, not recruiting
878 participants
Started: Sep 1, 2015 · Completed: Jun 30, 2025
1 condition1 sponsor21 locations
NCT02523040
Lenalidomide for Adult Histiocyte Disorders
PHASE2Active, not recruiting
12 participants
Started: Aug 31, 2015 · Completed: Aug 31, 2025
3 conditions2 sponsors1 location
NCT02523443
Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection
PHASE3Active, not recruiting
231 participants
Started: Aug 31, 2015 · Completed: Aug 31, 2026
2 conditions1 sponsor3 locations
NCT02572934
Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study)
N/AActive, not recruiting
281 participants
Started: Aug 31, 2015 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT02556762
Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal Cancer
PHASE3Active, not recruiting
202 participants
Started: Aug 31, 2015 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT02411812
Effects of the Herbst Appliance With Different Anchorages and Twin-Block Appliance in Class II Malocclusion
NAActive, not recruiting
60 participants
Started: Aug 31, 2015 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT02513394
PALbociclib CoLlaborative Adjuvant Study
PHASE3Active, not recruiting
5,796 participants
Started: Aug 31, 2015 · Completed: Dec 31, 2028
1 condition6 sponsors437 locations
NCT02738892
Zambian Preterm Birth Prevention Study
N/AActive, not recruiting
9,000 participants
Started: Aug 31, 2015 · Completed: Dec 31, 2026
3 conditions3 sponsors2 locations
NCT02498912
Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors
PHASE1Active, not recruiting
18 participants
Started: Aug 31, 2015 · Completed: Aug 31, 2026
1 condition3 sponsors1 location
NCT02427698
Cyrolipolysis vs Cyrolipolysis and Subcision for Cellulite
NAActive, not recruiting
15 participants
Started: Aug 31, 2015 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT02530697
The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil
PHASE2Active, not recruiting
160 participants
Started: Aug 31, 2015 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT02380716
ARISE: Evaluation of the GORE® Ascending Stent Graft in the Treatment of DeBakey Type I/II Aortic Dissection
N/AActive, not recruiting
21 participants
Started: Aug 31, 2015 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT02521103
Triathlon Tritanium Cone Augments Outcomes Study
NAActive, not recruiting
145 participants
Started: Aug 31, 2015 · Completed: Mar 31, 2028
3 conditions1 sponsor9 locations
NCT02238808
A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers
PHASE2Active, not recruiting
19 participants
Started: Aug 31, 2015 · Completed: Jun 30, 2028
1 condition1 sponsor1 location
NCT02538198
Lenalidomide Maintenance in Plasma Cell Myeloma
PHASE2Active, not recruiting
108 participants
Started: Aug 31, 2015 · Completed: Aug 31, 2026
1 condition1 sponsor6 locations
NCT02710968
Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Severe Left Diaphragmatic Hernia (CDH)
NAActive, not recruiting
21 participants
Started: Aug 31, 2015 · Completed: Mar 31, 2028
1 condition2 sponsors1 location
NCT03057730
A Clinical Trial Testing Root Coverage With Acellular Dermal Matrix in Thin and Thick Gingival Biotypes
PHASE4Active, not recruiting
34 participants
Started: Aug 31, 2015 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT02537548
Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma
NAActive, not recruiting
55 participants
Started: Aug 28, 2015 · Completed: Aug 28, 2027
3 conditions2 sponsors14 locations
NCT02601417
The Necessity of Bile Cultures in Patients With Acute Cholangitis
NAActive, not recruiting
440 participants
Started: Aug 27, 2015 · Completed: Jul 30, 2024
1 condition1 sponsor1 location
NCT02347995
Resistive Training Combined With Nutritional Therapy After Stroke
NAActive, not recruiting
93 participants
Started: Aug 24, 2015 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT02530177
Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer
N/AActive, not recruiting
546 participants
Started: Aug 19, 2015 · Completed: Aug 31, 2026
1 condition3 sponsors1 location
NCT02531087
Urinary Biomarkers of OI Pathobiology
N/AActive, not recruiting
25 participants
Started: Aug 17, 2015 · Completed: Aug 31, 2025
1 condition4 sponsors7 locations
NCT02465060
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
PHASE2Active, not recruiting
6,452 participants
Started: Aug 17, 2015 · Completed: Dec 31, 2026
52 conditions1 sponsor1416 locations
NCT02784080
Donor Specific HLA Alloantibodies in Liver Transplantation
N/AActive, not recruiting
858 participants
Started: Aug 15, 2015 · Completed: Dec 31, 2024
1 condition5 sponsors5 locations
NCT02491632
Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer
PHASE2/PHASE3Active, not recruiting
90 participants
Started: Aug 13, 2015 · Completed: Dec 31, 2026
5 conditions2 sponsors1 location
NCT02522715
Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer
PHASE1/PHASE2Active, not recruiting
37 participants
Started: Aug 13, 2015 · Completed: Jan 1, 2026
4 conditions2 sponsors3 locations
NCT04439279
Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)
PHASE2Active, not recruiting
35 participants
Started: Aug 12, 2015 · Completed: Mar 19, 2026
6 conditions1 sponsor1 location
NCT04439266
Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F)
PHASE2Active, not recruiting
5 participants
Started: Aug 12, 2015 · Completed: Mar 17, 2026
6 conditions1 sponsor1 location
NCT04439253
Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G)
PHASE2Active, not recruiting
4 participants
Started: Aug 12, 2015 · Completed: Mar 17, 2026
6 conditions1 sponsor1 location